Background The global number of type 2 diabetes (T2D) cases has been steadily increasing over the past few decades, becoming a major public health issue. Available toxicological research has indicated that ozone (O₃) can lead to oxidative stress and inflammatory responses, thereby causing metabolic changes and the development of T2D. Existing cohort studies on the impact of long-term O₃ exposure on the risk of developing T2D have reached contradictory conclusions, and the results have shown significant heterogeneity. Objective To summarize cohort studies on long-term O₃ exposure and T2D risk, and investigate heterogeneity sources in the association between O₃ and T2D. Methods Cohort studies on O₃ and T2D were searched through PubMed, Embase, and the Web of Science, with the search deadline set for 25 April, 2025. After two researchers independently screened the literature, extracted data, and evaluated the quality of the included studies, meta-analysis was conducted using Stata 18.0 software. We used a random effects model to calculate the overall relative risk (RR) of the standardized risk estimates and its 95% confidence interval (CI). Additionally, sensitivity analysis, subgroup analysis, meta-regression, and publication bias testing were performed to explore the sources of heterogeneity in the association between O₃ and T2D. Results In the 8 articles meeting predetermined inclusion criteria, a total of 11 cohort studies involving 54887070 participants were finally included. The results of the meta-analysis indicated that long-term exposure to O₃ was associated with a higher incidence of type 2 diabetes [standardized RR=1.04 (95%CI: 1.01, 1.07), P<0.001, I²=97.3%], and significant heterogeneity existed. The subgroup analysis showed that females (standardized RR=1.08, 95%CI: 1.03, 1.13) and the Asian population (standardized RR=1.09, 95%CI: 1.06, 1.11) were are more susceptible to O₃. The meta-regression model that included study region and average O₃ concentration variables explained 60.33% of the heterogeneity between studies. No significant evidence of publication bias was observed after the funnel plot test, Egger's test (P=0.437), Begg's test (P=0.640), and the trim-and-fill method. Conclusion Long-term exposure to O₃ could increase the risk of developing T2D, with females and Asian populations being particularly sensitive. The heterogeneity in the association between O₃ and T2D can be partly explained by factors such as average O₃ concentration and geographic location.

Objective:To investigate the prevalence status and the clinical characteristics of hepatitis D virus (HDV) among patients chronically infected with hepatitis B virus (HBV) in the Xinjiang region.Methods:A cross-sectional study was conducted. Serum samples from 1 830 patients with chronic HBV infection who visited the Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region from December 2022 to October 2023 were collected. All sera were tested for anti-HDV IgG and IgM. Sera positive for anti-HDV IgG or IgM were selected for HDV RNA detection. HDV RNA-positive sera were sequenced to determine the HDV genotype. Age, gender, HBV course, and anti-HBV treatment status were used as scoring items based on the propensity score matching (PSM) method. Chronic HBV patients with negative anti-HDV were matched in a ratio of 1∶1. The clinical characteristics of anti-HDV -positive-patients were analyzed. The t-test was used for comparison between groups of normally distributed continuous data. The Wilcoxon signed-rank test was used for comparison between groups of skewness distribution. The χ2 test was used for comparison between groups of enumeration data. Results:The positive detection rates of anti-HDV IgG, anti-HDV IgM, and HDV RNA in 1 830 cases with chronic HBV infection were 2.24% (41/1 830), 1.09% (20/1 830), and 1.69% (31/1 830), respectively. All HDV RNA-positive patients had HDV genotype 1. Two anti-HDV-positive patients had negative hepatitis B surface antigen (HBsAg). Gender, age, HBV course, and anti-HBV treatment status had no significant difference. The quantification of HBsAg, liver biochemical indexes (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and total bile acids), the proportion of patients with liver cirrhosis, and alpha-fetoprotein were significantly higher in the anti-HDV-positive group than in those in the anti-HDV-negative group ( P<0.05). Conclusion:The prevalence rate of HDV in chronic HBV-infected patients at a single center in the Xinjiang region was 2.24%, with the primary genotype being 1. Furthermore, overlap infection should be paid attention to because it might aggravate liver damage.

Objective:To investigate the prevalence status and the clinical characteristics of hepatitis D virus (HDV) among patients chronically infected with hepatitis B virus (HBV) in the Xinjiang region.Methods:A cross-sectional study was conducted. Serum samples from 1 830 patients with chronic HBV infection who visited the Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region from December 2022 to October 2023 were collected. All sera were tested for anti-HDV IgG and IgM. Sera positive for anti-HDV IgG or IgM were selected for HDV RNA detection. HDV RNA-positive sera were sequenced to determine the HDV genotype. Age, gender, HBV course, and anti-HBV treatment status were used as scoring items based on the propensity score matching (PSM) method. Chronic HBV patients with negative anti-HDV were matched in a ratio of 1∶1. The clinical characteristics of anti-HDV -positive-patients were analyzed. The t-test was used for comparison between groups of normally distributed continuous data. The Wilcoxon signed-rank test was used for comparison between groups of skewness distribution. The χ2 test was used for comparison between groups of enumeration data. Results:The positive detection rates of anti-HDV IgG, anti-HDV IgM, and HDV RNA in 1 830 cases with chronic HBV infection were 2.24% (41/1 830), 1.09% (20/1 830), and 1.69% (31/1 830), respectively. All HDV RNA-positive patients had HDV genotype 1. Two anti-HDV-positive patients had negative hepatitis B surface antigen (HBsAg). Gender, age, HBV course, and anti-HBV treatment status had no significant difference. The quantification of HBsAg, liver biochemical indexes (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and total bile acids), the proportion of patients with liver cirrhosis, and alpha-fetoprotein were significantly higher in the anti-HDV-positive group than in those in the anti-HDV-negative group ( P<0.05). Conclusion:The prevalence rate of HDV in chronic HBV-infected patients at a single center in the Xinjiang region was 2.24%, with the primary genotype being 1. Furthermore, overlap infection should be paid attention to because it might aggravate liver damage.